- We disseminate our news content on Twitter, Facebook and other social media channels. Also, news stories about publicly traded biotech companies are fed to more than a dozen investor-focused websites.
- The 2,000 subscribers to our monthly newsletter include representatives of San Diego biotech companies, universities, research institutes and venture capital firms, about 800 U.S. tech writers and editors, plus senior analysts with national investment banking firms.
- For the organizers of biotech-related conferences in San Diego, a suite of news, advertising and communications services designed to enhance event visibility.
Biotech jobs
- San Diego Biotechnology Connection provides a column titled “The Career Coach” as well as news stories relating to hiring the best and brightest job prospects and getting hired.
Biotechnology news
- We’re the most trusted source for regional biotech news: this website has 5,000 visitors per month and our “bounce rate” is less than 1 percent. About 68 percent of our visitors are from the U.S., and of those 61 are from California, with 62 percent of the Californians from the San Diego area.
- Our byline stories go beyond news releases to put companies, their products and technology in perspective.
- We provide third-party stories on contract with industry and academic clients that explain the stories that are new, hard-to-explain, under-appreciated or unrecognized.
Our approach
- Uniqueness and focus. We have an award-winning pedigree of achievement and our news and communications services are focused on the San Diego biotech sector.
- Your success is our business. We’re the most trusted source for regional biotech news: this website has 5,000 visitors per month and our “bounce rate” is less than 1 percent. About 68 percent of our visitors are from the U.S., and of those 61 are from California, with 62 of the Californians from the San Diego area.
- We get it. We have a unique mix of expertise, education and experience in biotechnology, life sciences and communications.
- Confidence. We aspire to the highest standards of professional ethics, and we are committed to secure communications and privacy protections.
- Tweet clout. Our strategic social media services give your enterprise more #oomf with the public, investors, journalists and financial analysts specializing in biotechnology.
